Cellply
Unravelling immune system function, one cell at a time
34 employees · est. 2013 · Bologna, Italy
EvolveImmune Therapeutics
Reimagining Cancer Immunotherapy
58 employees · est. 2020 · Branford, United States
Cellply is the older company (2013 vs 2020); EvolveImmune Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Cellply | EvolveImmune Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2020 |
| Headquarters | ||
| Headquarters | Bologna, Italy | Branford, United States |
| Employees | ||
| Employees | 34 | 58 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Undisclosed | Series Unknown |
| Total Funding | ||
| Total Funding | $17.44M | $54.95M |
| Funding Rounds | ||
| Funding Rounds | 7 | 2 |
| Services | ||
| Services | Not tracked yet | Development of trispecific T cell engagers, Partnerships for additional therapeutic development, Clinical trial management |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Healthcare institutions, Pharmaceutical companies |
| Taxonomy | ||
| Taxonomy | Life Science, Analytical Tools, Cancer Immunotherapies, Cell Therapies, Biotherapeutics, R&D Acceleration, Clinical Response Monitoring, Microfluidic Technologies, AI-powered Analytics, Single-cell Analysis, Co-Culture Array Technology, Drug Testing, Potency Evaluation, Immune System Function | Cancer Immunotherapy, Trispecific T Cell Engagers, CD2 Costimulation, EVOLVE Platform, Tumor Cell Resistance, Clinical Trials, Immune Activation, Tumor Targeting, Cytokine Secretion Amplification, Biotherapeutics Engineering, CD3 Bispecific Limitations, Immune Therapy Optimization, T-Cell Exhaustion, Immunobiological Platform, Tumor Cell Killing |
| Website | ||
| Website | cellply.com | evolveimmune.com |
About Cellply
Cellply is a biotechnology startup based in Italy, founded in 2013. The company's slogan "Unravelling immune system function, one cell at a time" reflects its core mission. Cellply is focused on developing next-generation analytical tools for in-depth characterization of cancer immunotherapies, cell...
About EvolveImmune Therapeutics
EvolveImmune Therapeutics, founded in 2020 and headquartered in the United States, is a biotechnology company creating innovative solutions for cancer treatment. Their slogan, "Reimagining Cancer Immunotherapy", reflects their ambitious approach in developing unique trispecific T cell engagers via t...
We will tell you when either one moves
BounceWatch watches Cellply and EvolveImmune Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cellply and EvolveImmune Therapeut... — by email.
Frequently Asked Questions
Compare Cellply with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cellply on 12 Sep 2024, and EvolveImmune Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
